Bradley Duffy

Array ( [id] => 11677198 [patent_doc_number] => 09675707 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-13 [patent_title] => 'Anti-TAT226 antibodies and immunoconjugates' [patent_app_type] => utility [patent_app_number] => 14/789873 [patent_app_country] => US [patent_app_date] => 2015-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 54720 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14789873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10654610 [patent_doc_number] => 20160000755 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-07 [patent_title] => 'COMPOSITIONS AND METHODS TO IMPROVE ADOPTIVE CELL THERAPIES' [patent_app_type] => utility [patent_app_number] => 14/754931 [patent_app_country] => US [patent_app_date] => 2015-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25887 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14754931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17635047 [patent_doc_number] => 11345760 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-31 [patent_title] => Multispecific antibody constructs [patent_app_type] => utility [patent_app_number] => 15/321055 [patent_app_country] => US [patent_app_date] => 2015-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 18326 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15321055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11743990 [patent_doc_number] => 20170198062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-07-13 [patent_title] => 'MULTI-SPECIFIC ANTIBODY CONSTRUCTS' [patent_app_type] => utility [patent_app_number] => 15/321061 [patent_app_country] => US [patent_app_date] => 2015-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17744 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15321061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12246297 [patent_doc_number] => 09919061 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-20 [patent_title] => 'CD19 binding agents and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/743318 [patent_app_country] => US [patent_app_date] => 2015-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 56467 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14743318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10705548 [patent_doc_number] => 20160051695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-25 [patent_title] => 'HER2 ANTIBODY-DRUG CONJUGATES' [patent_app_type] => utility [patent_app_number] => 14/743351 [patent_app_country] => US [patent_app_date] => 2015-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 27217 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14743351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12246297 [patent_doc_number] => 09919061 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-03-20 [patent_title] => 'CD19 binding agents and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/743318 [patent_app_country] => US [patent_app_date] => 2015-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 56467 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 178 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14743318 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10776574 [patent_doc_number] => 20160122730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-05-05 [patent_title] => 'NOVEL MOLECULES OF THE CARD-RELATED PROTEIN FAMILY AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/741530 [patent_app_country] => US [patent_app_date] => 2015-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 54890 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14741530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11335625 [patent_doc_number] => 20160361380 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-15 [patent_title] => 'COMBINATION COMPOSITIONS FOR TREATING DISORDERS REQUIRING REMOVAL OR DESTRUCTION OF UNWANTED CELLULAR PROLIFERATIONS' [patent_app_type] => utility [patent_app_number] => 14/738551 [patent_app_country] => US [patent_app_date] => 2015-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23048 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14738551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11588517 [patent_doc_number] => 20170112928 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-27 [patent_title] => 'COMBINATION THERAPIES TARGETING TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND TOPOISOMERASE' [patent_app_type] => utility [patent_app_number] => 15/317086 [patent_app_country] => US [patent_app_date] => 2015-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 14603 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11541751 [patent_doc_number] => 20170095575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-06 [patent_title] => 'COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND OTHER PATHWAYS' [patent_app_type] => utility [patent_app_number] => 15/317079 [patent_app_country] => US [patent_app_date] => 2015-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18883 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317079 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11588516 [patent_doc_number] => 20170112927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-27 [patent_title] => 'COMBINATION THERAPIES USING AGENTS THAT TARGET TUMOR-ASSOCIATED STROMA OR TUMOR CELLS AND ALKYLATING AGENTS' [patent_app_type] => utility [patent_app_number] => 15/317063 [patent_app_country] => US [patent_app_date] => 2015-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 15038 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317063 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11588515 [patent_doc_number] => 20170112926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-04-27 [patent_title] => 'COMBINATION THERAPIES USING ANTI-METABOLITES AND AGENTS THAT TARGET TUMOR-ASSOCIATED STROMA OR TUMOR CELLS' [patent_app_type] => utility [patent_app_number] => 15/317055 [patent_app_country] => US [patent_app_date] => 2015-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 14981 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15317055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13675223 [patent_doc_number] => 20160376345 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-29 [patent_title] => FIBRONECTIN-BASED BINDING MOLECULES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 14/729718 [patent_app_country] => US [patent_app_date] => 2015-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21138 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14729718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10430281 [patent_doc_number] => 20150315294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-05 [patent_title] => 'ACCEPTOR FRAMEWORK FOR CDR GRAFTING' [patent_app_type] => utility [patent_app_number] => 14/706484 [patent_app_country] => US [patent_app_date] => 2015-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10359 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14706484 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10340479 [patent_doc_number] => 20150225484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-13 [patent_title] => 'ANTIGEN-BINDING MOLECULE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/696754 [patent_app_country] => US [patent_app_date] => 2015-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13570 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14696754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11421361 [patent_doc_number] => 20170029505 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-02-02 [patent_title] => 'MULTIMERIC FC PROTEINS' [patent_app_type] => utility [patent_app_number] => 15/303625 [patent_app_country] => US [patent_app_date] => 2015-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12904 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15303625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11698868 [patent_doc_number] => 09688771 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-06-27 [patent_title] => 'Anti P2X7 receptor antibodies and fragments thereof' [patent_app_type] => utility [patent_app_number] => 14/671254 [patent_app_country] => US [patent_app_date] => 2015-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 23058 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14671254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10491252 [patent_doc_number] => 20150376273 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-31 [patent_title] => 'ANTIBODIES TO NTB-A' [patent_app_type] => utility [patent_app_number] => 14/670126 [patent_app_country] => US [patent_app_date] => 2015-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 46052 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14670126 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10374427 [patent_doc_number] => 20150259433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-17 [patent_title] => 'ANTI-MESOTHELIN ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/645411 [patent_app_country] => US [patent_app_date] => 2015-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 15507 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14645411 [rel_patent_id] =>[rel_patent_doc_number] =>)